- The natural killer cell immunotherapy platform: An overview of the landscape of clinical trials in liquid and solid tumors
Sara Piccinelli et al, 2023, Seminars in Hematology CrossRef - Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer
Xianwen Hu et al, 2022, Frontiers in Oncology CrossRef - SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers
Zhen Lu et al, 2022, Journal of Clinical Investigation CrossRef - BRCA Mutations and PARP Inhibitors in Breast and/or Ovarian Cancer Patients
Abdulrahim Gari et al, 2021, International Journal Of Pharmaceutical Research And Allied Sciences CrossRef - The Molecular Mechanisms of Actions, Effects, and Clinical Implications of PARP Inhibitors in Epithelial Ovarian Cancers: A Systematic Review
Chien-Hui Lau et al, 2022, International Journal of Molecular Sciences CrossRef - Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship
Pronoy Kanti Das et al, 2024, European Journal of Medicinal Chemistry CrossRef - Peripheral Neuropathy under Oncologic Therapies: A Literature Review on Pathogenetic Mechanisms
Mariarita Laforgia et al, 2021, International Journal of Molecular Sciences CrossRef - Prevalence of Clinically Relevant Germline BRCA Variants in a Large Unselected South African Breast and Ovarian Cancer Cohort: A Public Sector Experience
Nerina C. Van der Merwe et al, 2022, Frontiers in Genetics CrossRef - Small-Molecule–Mediated Stabilization of PP2A Modulates the Homologous Recombination Pathway and Potentiates DNA Damage-Induced Cell Death
Rita A. Avelar et al, 2023, Molecular Cancer Therapeutics CrossRef - Targeted inhibition of the ATR/CHK1 pathway overcomes resistance to olaparib and dysregulates DNA damage response protein expression in BRCA2MUT ovarian cancer cells
Łukasz Biegała et al, 2023, Scientific Reports CrossRef - Niraparib treatment for patients with BRCA -mutated ovarian cancer: review of clinical data and therapeutic context
Antonio González-Martín et al, 2022, Future Oncology CrossRef - Synergistic cytotoxicity of irinotecan combined with polysaccharide-based nanoparticles for colorectal carcinoma
Fang-Ting Pai et al, 2023, Biomaterials Advances CrossRef - Machine Learning Quantification of Intraepithelial Tumor-Infiltrating Lymphocytes as a Significant Prognostic Factor in High-Grade Serous Ovarian Carcinomas
Jesús Machuca-Aguado et al, 2023, International Journal of Molecular Sciences CrossRef - Homologous Recombination Deficiencies and Hereditary Tumors
Hideki Yamamoto et al, 2021, International Journal of Molecular Sciences CrossRef - Expression of PAWR predicts prognosis of ovarian cancer
Jiahong Tan et al, 2020, Cancer Cell International CrossRef